Molecular Partners AG (MOLN)
3.87
+0.16
(+4.31%)
USD |
NASDAQ |
May 16, 16:00
Molecular Partners Price: 3.87 for May 16, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 16, 2024 | 3.87 | 3.87 | 3.87 | 3.87 | 113.00 |
| May 15, 2024 | 3.632 | 3.71 | 3.53 | 3.71 | 1730.00 |
| May 14, 2024 | 3.680 | 3.680 | 3.548 | 3.548 | 1508.00 |
| May 13, 2024 | 3.80 | 3.80 | 3.80 | 3.80 | 0.000 |
| May 10, 2024 | 3.70 | 4.07 | 3.70 | 3.80 | 661.00 |
| May 09, 2024 | 3.95 | 4.49 | 3.701 | 3.701 | 3086.00 |
| May 08, 2024 | 3.67 | 3.76 | 3.67 | 3.76 | 645.00 |
| May 07, 2024 | 3.83 | 3.92 | 3.575 | 3.65 | 7707.00 |
| May 06, 2024 | 3.83 | 4.21 | 3.61 | 3.61 | 4436.00 |
| May 03, 2024 | 3.96 | 4.20 | 3.92 | 3.98 | 2011.00 |
| May 02, 2024 | 3.88 | 4.025 | 3.765 | 3.765 | 16919.00 |
| May 01, 2024 | 3.765 | 4.272 | 3.60 | 3.87 | 4917.00 |
| Apr 30, 2024 | 3.97 | 3.97 | 3.78 | 3.781 | 4726.00 |
| Apr 29, 2024 | 3.60 | 3.96 | 3.60 | 3.70 | 2558.00 |
| Apr 26, 2024 | 3.88 | 3.88 | 3.88 | 3.88 | 254.00 |
| Apr 25, 2024 | 3.88 | 3.88 | 3.88 | 3.88 | 0.000 |
| Apr 24, 2024 | 3.88 | 3.88 | 3.88 | 3.88 | 0.000 |
| Apr 23, 2024 | 3.88 | 3.88 | 3.88 | 3.88 | 0.000 |
| Apr 22, 2024 | 3.721 | 3.89 | 3.721 | 3.88 | 3548.00 |
| Apr 19, 2024 | 3.67 | 3.775 | 3.32 | 3.32 | 6210.00 |
| Apr 18, 2024 | 3.74 | 3.74 | 3.74 | 3.74 | 319.00 |
| Apr 17, 2024 | 3.91 | 3.91 | 3.91 | 3.91 | 0.000 |
| Apr 16, 2024 | 3.93 | 3.94 | 3.78 | 3.91 | 3162.00 |
| Apr 15, 2024 | 3.95 | 3.95 | 3.95 | 3.95 | 6584.00 |
| Apr 12, 2024 | 3.835 | 4.90 | 3.61 | 3.95 | 13546.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
3.32
Minimum
Apr 19 2024
31.89
Maximum
Jan 14 2022
9.995
Average
6.54
Median
Jun 13 2022
Price Benchmarks
| AC Immune SA | 3.21 |
| CRISPR Therapeutics AG | 56.19 |
| Addex Therapeutics Ltd | 8.78 |
| NLS Pharmaceutics Ltd | 0.1533 |
| MoonLake Immunotherapeutics | 39.74 |
Price Related Metrics
| PS Ratio | 16.27 |
| Price to Book Value | 0.6053 |
| Earnings Yield | -54.38% |
| Market Cap | 127.15M |